Mitchell Sinkler & Starr’s Edwards Lifesciences EW Stock Holding History

Mitchell Sinkler & Starr’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Hold	2,900	–	–	0.11%	138
2026 Q1	$232K	Hold	2,900	–	–	0.11%	137
2025 Q4	$247K	Buy	2,900 +175	+6%	+$14.4K	0.11%	131
2025 Q3	$212K	Sell	2,725 -75	-3%	-$5.86K	0.1%	139
2025 Q2	$219K	Hold	2,800	–	–	0.1%	136
2025 Q1	$203K	Hold	2,800	–	–	0.06%	151
2024 Q4	$207K	Buy	+2,800	New	+$196K	0.06%	154
2024 Q3	–	Sell	-2,800	Closed	-$240K	–	191
2024 Q2	$240K	Buy	+2,800	New	+$248K	0.06%	140
2023 Q3	–	Sell	-2,800	Closed	-$264K	–	109
2023 Q2	$264K	Hold	2,800	–	–	0.08%	127
2023 Q1	$232K	Hold	2,800	–	–	0.07%	133
2022 Q4	$209K	Buy	+2,800	New	+$216K	0.07%	136
2021 Q1	–	Sell	-3,750	Closed	-$342K	–	102
2020 Q4	$342K	Hold	3,750	–	–	0.33%	76
2020 Q3	$299K	Hold	3,750	–	–	0.3%	78
2020 Q2	$259K	Buy	+3,750	New	+$266K	0.29%	83
2020 Q1	–	Sell	-3,150	Closed	-$245K	–	97
2019 Q4	$245K	Buy	+3,150	New	+$246K	0.26%	89

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Mitchell Sinkler & Starr's EW Position: Q2 2026 in Review

Mitchell Sinkler & Starr held its Edwards Lifesciences (EW) position steady in Q2 2026 at 2,900 shares worth $262K. The position accounts for 0.11% of the portfolio, ranked #138.

Mitchell Sinkler & Starr first reported a position in EW in Q4 2019 and has held it in 15 quarters since. The position peaked at $342K in Q4 2020. 368 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Mitchell Sinkler & Starr held 2,900 shares of Edwards Lifesciences worth $262K as of Q2 2026.
Mitchell Sinkler & Starr left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.11% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #138 holding.
Mitchell Sinkler & Starr first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 15 quarters since.
Mitchell Sinkler & Starr's Edwards Lifesciences position peaked at $342K in Q4 2020.
368 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.